Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Herpes Virus | Case report

Hemolytic uremic syndrome related to Shiga-like toxin-producing Escherichia coli with encephalitis hiding a human herpesvirus-6 infection: a case report

Authors: Sophie Mounier, Arthur Gavotto, Julie Tenenbaum, Pierre Meyer, Marc Fila, Julien Baleine

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

Cardiac and neurological involvement in hemolytic uremic syndrome are life-threatening complications. The most frequent complications of cardiac involvement in hemolytic uremic syndrome are myocarditis and cardiac dysfunction due to fluid overload. Pericarditis remains very rare in hemolytic uremic syndrome. To our knowledge, only five cases of cardiac tamponade associated with hemolytic uremic syndrome have been described in literature.

Case summary

A 27-month-old Caucasian girl presented with symptoms of nonbloody diarrhea and tonic-clonic seizures. The diagnosis of Shiga-like toxin-producing Escherichia coli hemolytic uremic syndrome with central nervous system involvement was made, and stool examination revealed infection with a Shiga-like toxin-producing Escherichia coli. She did not need renal replacement therapy but had severe neurological impairment. The patient’s course was complicated by pericardial effusion. A pericardiocentesis was performed via an apical approach because the pericardial effusion was predominantly surrounding the left ventricle. Effusion analysis showed an exudate and positivity for human herpesvirus-6B on polymerase chain reaction with viremia. This finding was consistent with primary human herpesvirus-6 infection with encephalitis.

Conclusion

We report this uncommon case of Shiga-like toxin-producing Escherichia coli hemolytic uremic syndrome associated with a severe human herpesvirus-6 infection. Secondary isolated pericardial effusion and atypical neurological involvement are uncommon in Shiga-like toxin-producing Escherichia coli hemolytic uremic syndrome and should lead the physician to perform additional investigations.
Literature
1.
go back to reference Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035.CrossRef Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035.CrossRef
2.
go back to reference Ardissino G, Salardi S, Colombo E, Testa S, Borsa-Ghiringhelli N, Paglialonga F, et al. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Pediatr. 2016;175(4):465–73.CrossRef Ardissino G, Salardi S, Colombo E, Testa S, Borsa-Ghiringhelli N, Paglialonga F, et al. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Pediatr. 2016;175(4):465–73.CrossRef
3.
go back to reference Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681–96.CrossRef Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681–96.CrossRef
4.
go back to reference Khalid M, Andreoli S. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol. 2019;34(12):2495–507.CrossRef Khalid M, Andreoli S. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol. 2019;34(12):2495–507.CrossRef
5.
go back to reference Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, et al. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol. 2019;34(3):517–27.CrossRef Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, et al. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol. 2019;34(3):517–27.CrossRef
6.
go back to reference Rigamonti D, Simonetti GD. Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature. Eur J Pediatr. 2016;175(12):1927–31.CrossRef Rigamonti D, Simonetti GD. Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature. Eur J Pediatr. 2016;175(12):1927–31.CrossRef
7.
go back to reference Mohammed J, Filler G, Price A, Sharma AP. Cardiac tamponade in diarrhoea-positive haemolytic uraemic syndrome. Nephrol Dial Transplant. 2008;24(2):679–81.CrossRef Mohammed J, Filler G, Price A, Sharma AP. Cardiac tamponade in diarrhoea-positive haemolytic uraemic syndrome. Nephrol Dial Transplant. 2008;24(2):679–81.CrossRef
8.
go back to reference Joanna HPY, Bob KF, Emma JB, Tamsin H, Maria EC. A preventable illness? Purulent pericarditis due to Streptococcus pneumoniae complicated by haemolytic uraemic syndrome in an infant. Commun Dis Intell. 2005;29:158. Joanna HPY, Bob KF, Emma JB, Tamsin H, Maria EC. A preventable illness? Purulent pericarditis due to Streptococcus pneumoniae complicated by haemolytic uraemic syndrome in an infant. Commun Dis Intell. 2005;29:158.
9.
go back to reference Leichter H, Hellwege HH, Altrogge H. Severe course of a hemolytic-uremic syndrome. Monatsschr Kinderheilkd. 1982;130:849–51.PubMed Leichter H, Hellwege HH, Altrogge H. Severe course of a hemolytic-uremic syndrome. Monatsschr Kinderheilkd. 1982;130:849–51.PubMed
10.
go back to reference Utting JA, Shreeve DR. Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy. BMJ. 1973;2(5866):591–591.CrossRef Utting JA, Shreeve DR. Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy. BMJ. 1973;2(5866):591–591.CrossRef
11.
go back to reference Birk PE, Chakrabarti S, Lacson AG, Ogborn MR. Cardiac tamponade as a terminal event in the hemolytic uremic syndrome in childhood. Pediatr Nephrol. 1994;8(6):754–5.CrossRef Birk PE, Chakrabarti S, Lacson AG, Ogborn MR. Cardiac tamponade as a terminal event in the hemolytic uremic syndrome in childhood. Pediatr Nephrol. 1994;8(6):754–5.CrossRef
12.
go back to reference Mannonen L, Herrgård E, Valmari P, Rautiainen P, Uotila K, Aine M-R, et al. Primary human herpesvirus-6 infection in the central nervous system can cause severe disease. Pediatr Neurol. 2007;37(3):186–91.CrossRef Mannonen L, Herrgård E, Valmari P, Rautiainen P, Uotila K, Aine M-R, et al. Primary human herpesvirus-6 infection in the central nervous system can cause severe disease. Pediatr Neurol. 2007;37(3):186–91.CrossRef
13.
go back to reference Daibata M, Ido E, Murakami K, Kuzume T, Kubonishi I, Taguchi H, et al. Angioimmunoblastic lymphadenopathy with disseminated human herpesvirus 6 infection in a patient with acute myeloblastic leukemia. Leukemia. 1997;11(6):882–5.CrossRef Daibata M, Ido E, Murakami K, Kuzume T, Kubonishi I, Taguchi H, et al. Angioimmunoblastic lymphadenopathy with disseminated human herpesvirus 6 infection in a patient with acute myeloblastic leukemia. Leukemia. 1997;11(6):882–5.CrossRef
14.
go back to reference Ckerstedt KH, Lautenschlager I. Human herpesvirus-6 and acute liver failure. PLoS ONE. 2003;76(3):4. Ckerstedt KH, Lautenschlager I. Human herpesvirus-6 and acute liver failure. PLoS ONE. 2003;76(3):4.
15.
go back to reference Yoshikawa T, Ihira M, Suzuki K, Suga S, Kito H, Iwasaki T, et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol. 2001;54(10):792–5.CrossRef Yoshikawa T, Ihira M, Suzuki K, Suga S, Kito H, Iwasaki T, et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol. 2001;54(10):792–5.CrossRef
16.
go back to reference Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, et al. Chromosomally integrated human herpesvirus 6: questions and answers: ciHHV-6 Q & A. Rev Med Virol. 2012;22(3):144–55.CrossRef Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, et al. Chromosomally integrated human herpesvirus 6: questions and answers: ciHHV-6 Q & A. Rev Med Virol. 2012;22(3):144–55.CrossRef
17.
go back to reference Hara S, Kimura H, Hoshino Y, Tanaka N, Nishikawa K, Ihira M, et al. Detection of herpesvirus DNA in the serum of immunocompetent children. Microbiol Immunol. 2002;46(3):177–80.CrossRef Hara S, Kimura H, Hoshino Y, Tanaka N, Nishikawa K, Ihira M, et al. Detection of herpesvirus DNA in the serum of immunocompetent children. Microbiol Immunol. 2002;46(3):177–80.CrossRef
18.
go back to reference Cheng W. Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS. Front Biosci. 2012;17(1):1648.CrossRef Cheng W. Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS. Front Biosci. 2012;17(1):1648.CrossRef
19.
go back to reference Eliassen E, Hemond CC, Santoro JD. HHV-6-associated neurological disease in children: epidemiologic, clinical, diagnostic, and treatment considerations. Pediatr Neurol. 2020;105:10–20.CrossRef Eliassen E, Hemond CC, Santoro JD. HHV-6-associated neurological disease in children: epidemiologic, clinical, diagnostic, and treatment considerations. Pediatr Neurol. 2020;105:10–20.CrossRef
20.
go back to reference Trachtman H, Austin C, Lewinski M, Stahl RAK. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012;8(11):658–69.CrossRef Trachtman H, Austin C, Lewinski M, Stahl RAK. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012;8(11):658–69.CrossRef
Metadata
Title
Hemolytic uremic syndrome related to Shiga-like toxin-producing Escherichia coli with encephalitis hiding a human herpesvirus-6 infection: a case report
Authors
Sophie Mounier
Arthur Gavotto
Julie Tenenbaum
Pierre Meyer
Marc Fila
Julien Baleine
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02873-8

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue